Reduction in vaccine-type human papillomavirus prevalence among women in the United States, 2009-2012

Abbey B. Berenson, Tabassum Haque Laz, Mahbubur Rahman

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Between 2009 and 2012, the proportion of young women in the United States completing the human papillomavirus (HPV) vaccine doubled. To understand how quickly this increased uptake is affecting women in the United States, we evaluated the prevalence of vaccine-type (VT) HPV strains among young women in national data sets from 2009-2010 and 2011-2012. Among 18-26-year-old women, the prevalence of VT HPV decreased markedly over a short interval, from 15.4% in 2009-2010 to 8.5% in 2011-2012 (prevalence ratio, 0.51; 95% confidence interval, .28-.92), and the prevalence of high-risk VT HPV decreased from 13.1% to 6.5% (0.46; .25-.86). Reductions in HPV-related diseases will probably follow.

Original languageEnglish (US)
Pages (from-to)1961-1964
Number of pages4
JournalJournal of Infectious Diseases
Volume214
Issue number12
DOIs
StatePublished - Dec 1 2016

Fingerprint

Papillomavirus Vaccines
Confidence Intervals

Keywords

  • HPV vaccine
  • Human papillomavirus
  • Prevalence
  • Young adults

ASJC Scopus subject areas

  • Immunology and Allergy
  • Infectious Diseases

Cite this

Reduction in vaccine-type human papillomavirus prevalence among women in the United States, 2009-2012. / Berenson, Abbey B.; Haque Laz, Tabassum; Rahman, Mahbubur.

In: Journal of Infectious Diseases, Vol. 214, No. 12, 01.12.2016, p. 1961-1964.

Research output: Contribution to journalArticle

@article{4a396eec2ba044baae5f89f7d1cdfd79,
title = "Reduction in vaccine-type human papillomavirus prevalence among women in the United States, 2009-2012",
abstract = "Between 2009 and 2012, the proportion of young women in the United States completing the human papillomavirus (HPV) vaccine doubled. To understand how quickly this increased uptake is affecting women in the United States, we evaluated the prevalence of vaccine-type (VT) HPV strains among young women in national data sets from 2009-2010 and 2011-2012. Among 18-26-year-old women, the prevalence of VT HPV decreased markedly over a short interval, from 15.4{\%} in 2009-2010 to 8.5{\%} in 2011-2012 (prevalence ratio, 0.51; 95{\%} confidence interval, .28-.92), and the prevalence of high-risk VT HPV decreased from 13.1{\%} to 6.5{\%} (0.46; .25-.86). Reductions in HPV-related diseases will probably follow.",
keywords = "HPV vaccine, Human papillomavirus, Prevalence, Young adults",
author = "Berenson, {Abbey B.} and {Haque Laz}, Tabassum and Mahbubur Rahman",
year = "2016",
month = "12",
day = "1",
doi = "10.1093/infdis/jiw515",
language = "English (US)",
volume = "214",
pages = "1961--1964",
journal = "Journal of Infectious Diseases",
issn = "0022-1899",
publisher = "Oxford University Press",
number = "12",

}

TY - JOUR

T1 - Reduction in vaccine-type human papillomavirus prevalence among women in the United States, 2009-2012

AU - Berenson, Abbey B.

AU - Haque Laz, Tabassum

AU - Rahman, Mahbubur

PY - 2016/12/1

Y1 - 2016/12/1

N2 - Between 2009 and 2012, the proportion of young women in the United States completing the human papillomavirus (HPV) vaccine doubled. To understand how quickly this increased uptake is affecting women in the United States, we evaluated the prevalence of vaccine-type (VT) HPV strains among young women in national data sets from 2009-2010 and 2011-2012. Among 18-26-year-old women, the prevalence of VT HPV decreased markedly over a short interval, from 15.4% in 2009-2010 to 8.5% in 2011-2012 (prevalence ratio, 0.51; 95% confidence interval, .28-.92), and the prevalence of high-risk VT HPV decreased from 13.1% to 6.5% (0.46; .25-.86). Reductions in HPV-related diseases will probably follow.

AB - Between 2009 and 2012, the proportion of young women in the United States completing the human papillomavirus (HPV) vaccine doubled. To understand how quickly this increased uptake is affecting women in the United States, we evaluated the prevalence of vaccine-type (VT) HPV strains among young women in national data sets from 2009-2010 and 2011-2012. Among 18-26-year-old women, the prevalence of VT HPV decreased markedly over a short interval, from 15.4% in 2009-2010 to 8.5% in 2011-2012 (prevalence ratio, 0.51; 95% confidence interval, .28-.92), and the prevalence of high-risk VT HPV decreased from 13.1% to 6.5% (0.46; .25-.86). Reductions in HPV-related diseases will probably follow.

KW - HPV vaccine

KW - Human papillomavirus

KW - Prevalence

KW - Young adults

UR - http://www.scopus.com/inward/record.url?scp=85016066317&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85016066317&partnerID=8YFLogxK

U2 - 10.1093/infdis/jiw515

DO - 10.1093/infdis/jiw515

M3 - Article

VL - 214

SP - 1961

EP - 1964

JO - Journal of Infectious Diseases

JF - Journal of Infectious Diseases

SN - 0022-1899

IS - 12

ER -